Autoimmune Encephalitis

• CLINICAL_TRIALS research · 2025-01-06
  Clinical Trial Update: A Multicentric Cohort of Autoimmune Encephalitis

  This document describes a multicenter cohort study investigating autoimmune encephalitis. The sponsor is Xuanwu Hospital, Beijing, and the t…

• CLINICAL_TRIALS research · 2024-12-27
  Clinical Trial Update: Risk Prediction Model for Severe Autoimmune Encephalitis

  A ClinicalTrials.gov entry describes a study to develop a risk prediction model for autoimmune encephalitis, with the trial not yet recruiti…

• CLINICAL_TRIALS research · 2024-11-20
  Clinical Trial Update: Biomarkers in Autoimmune Disease of Nervous System

  A Tongji Hospital clinical trial is recruiting to study biomarkers in autoimmune diseases of the nervous system, including Neuromyelitis Opt…

• CLINICAL_TRIALS research · 2024-10-30
  Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]

  An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …

• CLINICAL_TRIALS research · 2024-06-13
  Clinical Trial Update: Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment

  A clinical trial update focusing on clinical features and prognostic markers in adult autoimmune encephalitis patients admitted to the ICU, …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2024-06-05
  Clinical Trial Update: National, Multicentric Registry Study on Neuroimmunological Diseases in China

  National multicentric registry in China studying neuroimmunological diseases is currently recruiting, covering conditions such as Multiple S…

• CLINICAL_TRIALS research · 2024-05-29
  Clinical Trial Update: Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS

  A clinical trial evaluating metabolic imaging for diagnosis and prognostication in autoimmune encephalitis and paraneoplastic neurological s…

• CLINICAL_TRIALS trial_result · 2022-12-01
  Clinical Trial Update: Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis [Phase 3]

  Phase III clinical study of NPB-01 in autoimmune encephalitis is ongoing with no status available.

• CLINICAL_TRIALS trial_result · 2021-10-19
  Clinical Trial Update: Efficacy of Ocrelizumab in Autoimmune Encephalitis [Phase 2]

  Phase 2 trial assessing efficacy of ocrelizumab in autoimmune encephalitis has been terminated with posted results.

• CLINICAL_TRIALS withdrawal · 2021-09-29
  Clinical Trial Update: Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients [Phase 4]

  A Phase 4 clinical trial investigating erythropoietin in refractory autoimmune encephalitis has been withdrawn.

• CLINICAL_TRIALS trial_result · 2020-06-30
  Clinical Trial Update: Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: [Phase 2]

  Phase 2 trial evaluating safety and efficacy of IGIV 10% in autoimmune encephalitis has completed.

• CLINICAL_TRIALS research · 2018-05-21
  Clinical Trial Update: To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI

  A completed clinical trial investigating cognitive neural mechanisms of autoimmune encephalitis using neuropsychological tests and multi-mod…

• CLINICAL_TRIALS research · 2015-09-29
  Clinical Trial Update: Multicenter and Prospective Clinical Registry Study of Autoimmune Encephalitis in China

  Clinical trial update describing a multicenter, prospective registry study of autoimmune encephalitis in China, with the study status curren…

• CLINICAL_TRIALS trial_result · 2014-09-01
  Clinical Trial Update: IVIG Treatment for Refractory Immune-Related Adult Epilepsy [Phase 2]

  Phase 2 trial of intravenous immunoglobulin (IVIG) for refractory immune-related epilepsy was terminated. Results have been posted.